235 related articles for article (PubMed ID: 28956156)
41. Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.
Cao Y; Zhang Y; Shih G; Zhang Y; Bohmart A; Hecht EM; Prince MR
Invest Radiol; 2016 Nov; 51(11):677-682. PubMed ID: 27272543
[TBL] [Abstract][Full Text] [Related]
42. One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model.
Robert P; Fingerhut S; Factor C; Vives V; Letien J; Sperling M; Rasschaert M; Santus R; Ballet S; Idée JM; Corot C; Karst U
Radiology; 2018 Aug; 288(2):424-433. PubMed ID: 29786486
[TBL] [Abstract][Full Text] [Related]
43. Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents.
Chehabeddine L; Al Saleh T; Baalbaki M; Saleh E; Khoury SJ; Hannoun S
Crit Rev Toxicol; 2019 Mar; 49(3):262-279. PubMed ID: 30942117
[TBL] [Abstract][Full Text] [Related]
44. Gadolinium Distribution in Cerebrospinal Fluid after Administration of a Gadolinium-based MR Contrast Agent in Humans.
Berger F; Kubik-Huch RA; Niemann T; Schmid HR; Poetzsch M; Froehlich JM; Beer JH; Thali MJ; Kraemer T
Radiology; 2018 Sep; 288(3):703-709. PubMed ID: 29737953
[TBL] [Abstract][Full Text] [Related]
45. Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
Raynaud JS; Darmon-Kern E; Lancelot E; Laurent AC; Desché P
Radiol Med; 2018 Jun; 123(6):432-433. PubMed ID: 29476438
[No Abstract] [Full Text] [Related]
46. CAIPIRINHA-Dixon-TWIST (CDT)-volume-interpolated breath-hold examination (VIBE) for dynamic liver imaging: comparison of gadoterate meglumine, gadobutrol and gadoxetic acid.
Budjan J; Ong M; Riffel P; Morelli JN; Michaely HJ; Schoenberg SO; Haneder S
Eur J Radiol; 2014 Nov; 83(11):2007-12. PubMed ID: 25172427
[TBL] [Abstract][Full Text] [Related]
47. Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.
Bussi S; Coppo A; Botteron C; Fraimbault V; Fanizzi A; De Laurentiis E; Colombo Serra S; Kirchin MA; Tedoldi F; Maisano F
J Magn Reson Imaging; 2018 Mar; 47(3):746-752. PubMed ID: 28730643
[TBL] [Abstract][Full Text] [Related]
48. Reply to: RE: effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain-a retrospective study in 158 multiple sclerosis (MS) patients.
Splendiani A
Radiol Med; 2018 Jul; 123(7):535-537. PubMed ID: 29560604
[No Abstract] [Full Text] [Related]
49. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
Jaulent P; Hannoun S; Kocevar G; Rollot F; Durand-Dubief F; Vukusic S; Brisset JC; Sappey-Marinier D; Cotton F
Eur J Radiol; 2018 Aug; 105():204-208. PubMed ID: 30017281
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of toxicity of gadolinium-based contrast agents on neuronal cells.
Erdoğan MA; Apaydin M; Armagan G; Taskiran D
Acta Radiol; 2021 Feb; 62(2):206-214. PubMed ID: 32366109
[TBL] [Abstract][Full Text] [Related]
51. Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration.
Ayers-Ringler J; McDonald JS; Connors MA; Fisher CR; Han S; Jakaitis DR; Scherer B; Tutor G; Wininger KM; Dai D; Choi DS; Salisbury JL; Jannetto PJ; Bornhorst JA; Kadirvel R; Kallmes DF; McDonald RJ
Radiology; 2022 Mar; 302(3):676-683. PubMed ID: 34931861
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
[TBL] [Abstract][Full Text] [Related]
53. Elemental bioimaging and transcriptomics reveal unchanged gene expression in mouse cerebellum following a single injection of Gadolinium-based contrast agents.
Richter H; Koke A; Soschinski PN; Martin LF; Bücker P; Sperling M; Karst U; Radbruch A; Witten A; Jeibmann A
Sci Rep; 2023 Apr; 13(1):6844. PubMed ID: 37100846
[TBL] [Abstract][Full Text] [Related]
54. Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America.
Mithal LB; Patel PS; Mithal D; Palac HL; Rozenfeld MN
Pediatr Radiol; 2017 May; 47(6):657-664. PubMed ID: 28283727
[TBL] [Abstract][Full Text] [Related]
55. Non-clinical safety assessment of gadoterate meglumine (Dotarem(®)) in neonatal and juvenile rats.
Giorgi H; Ammerman J; Briffaux JP; Fretellier N; Corot C; Bourrinet P
Regul Toxicol Pharmacol; 2015 Dec; 73(3):960-70. PubMed ID: 26382613
[TBL] [Abstract][Full Text] [Related]
56. Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents.
Zhang Y; Cao Y; Shih GL; Hecht EM; Prince MR
Radiology; 2017 Feb; 282(2):516-525. PubMed ID: 27513848
[TBL] [Abstract][Full Text] [Related]
57. Are some agents less likely to deposit gadolinium in the brain?
Radbruch A
Magn Reson Imaging; 2016 Dec; 34(10):1351-1354. PubMed ID: 27629022
[TBL] [Abstract][Full Text] [Related]
58. Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
Schlemm L; Chien C; Bellmann-Strobl J; Dörr J; Wuerfel J; Brandt AU; Paul F; Scheel M
Mult Scler; 2017 Jun; 23(7):963-972. PubMed ID: 27679460
[TBL] [Abstract][Full Text] [Related]
59. Skin Toxicity After Exposure to Gadolinium-Based Contrast Agents in Normal Renal Function, Using Clinical Approved Doses: Current Status of Preclinical and Clinical Studies.
Parillo M; Mallio CA; Van der Molen AJ; Rovira À; Ramalho J; Ramalho M; Gianolio E; Karst U; Radbruch A; Stroomberg G; Clement O; Dekkers IA; Nederveen AJ; Quattrocchi CC;
Invest Radiol; 2023 Aug; 58(8):530-538. PubMed ID: 37185158
[TBL] [Abstract][Full Text] [Related]
60. Gadolinium Tissue Distribution in a Large-Animal Model after a Single Dose of Gadolinium-based Contrast Agents.
Richter H; Bücker P; Martin LF; Dunker C; Fingerhut S; Xia A; Karol A; Sperling M; Karst U; Radbruch A; Jeibmann A
Radiology; 2021 Dec; 301(3):637-642. PubMed ID: 34546128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
